SCHEMBL31032002

SCHEMBL31032002

CC(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2cnc3c(=O)[nH]c(NC(=O)C(C)C)nc32)[C@@]1(O)C(C)=O

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
POLA1 P09884 1/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 1/20 0.37
ADORA2A P29274 4/20 0.35
TAAR1 Q96RJ0 1/20 0.34
ADA P00813 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
ALOX15 P16050 1/20 0.33
HINT1 P49773 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7251830 0.85 KDM4E (0.56) KDM4ETAS1R3TAS1R1POLA1HPGD
SCHEMBL6223639 0.85 HPGD (0.48) TAS1R3TAS1R1MEN1KMT2AHPGD
SCHEMBL29138074 0.83 KDM4E (0.58) KDM4ETAS1R3TAS1R1POLA1HPGD
SCHEMBL24049319 0.82 KDM4E (0.57) KDM4ETAS1R3TAS1R1MEN1KMT2A
SCHEMBL24049587 0.82 KDM4E (0.57) KDM4ETAS1R3TAS1R1MEN1KMT2A
SCHEMBL38653234 0.82 KDM4E (0.57) KDM4ETAS1R3TAS1R1POLA1HPGD
SCHEMBL25589113 0.82 KDM4E (0.57) KDM4ETAS1R3TAS1R1MEN1KMT2A
SCHEMBL29546774 0.82 KDM4E (0.58) KDM4ETAS1R3TAS1R1MEN1KMT2A
SCHEMBL24941679 0.82 KDM4E (0.58) KDM4ETAS1R3TAS1R1MEN1KMT2A
SCHEMBL18490261 0.82 KDM4E (0.58) KDM4ETAS1R3TAS1R1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658664-A1 CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE CureVac SE (DE) 2025-12-10 EP disclosed
WO-2024160895-A1 CAP ANALOGS WITH 5'-TERMINAL ACYCLIC GUANOSINE DERIVATIVE CureVac SE (DE) 2024-08-08 WO disclosed